Fate Therapeutics to Participate in Leerink Partners 2026 Global Healthcare Conference

Core Insights - Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies for cancer and autoimmune diseases [3] Company Overview - The company utilizes a proprietary iPSC product platform to create multiplexed-engineered master iPSC lines and manufacture off-the-shelf, iPSC-derived cell products [3] - Fate Therapeutics has established a leadership position in the clinical development of iPSC-derived T-cell and natural killer (NK) cell product candidates, which are designed to deliver multiple therapeutic mechanisms [3] - The company is headquartered in San Diego, California [3] Upcoming Events - Management will participate in a fireside chat at the Leerink Partners 2026 Global Healthcare Conference on March 9, 2026, at 9:20 AM ET [2] - A live webcast of the fireside chat will be available on the company's website, with an archived replay accessible for 90 days post-event [2]